摘要
一些早期的研究报道显示,对于选择性的前列腺癌患者,高强度聚焦超声(HIFU)是一种有效的治疗方法。目前有两种设备用于前列腺癌的HIFU治疗,即美国生产的Sonablate设备和法国生产的Ablatherm设备。一些研究初步发现HIFU对前列腺癌患者的治疗结果 (如生化无病生存率、前列腺特异性抗原、术后前列腺穿刺活检阴性)良好。另外,对于前列腺癌放射治疗后局部复发的患者,HIFU是潜在的治疗方式。本文就HIFU在前列腺癌治疗中的应用进展进行综述。
Some early researches suggest that high intensity focused ultrasound (HIFU) is effective on selected patients with prostate cancers. Two devices are currently used for the treatment of prostate cancer with HIFU: Sonablate (USA) and Ablatherm (France) . The outcomes [ ie, biochemical free survival rate (BFSR), prostate special antigen (PSA) and negative postoperative prostate biopsies] achieved for primary - care prostate cancer patients are very satisfactory. Moreover, HIFU is a potential treatment for local recurrence after radiation failure.
出处
《中国全科医学》
CAS
CSCD
北大核心
2011年第36期4124-4127,共4页
Chinese General Practice
关键词
前列腺肿瘤
超声
高强聚焦
治疗
Prostatic neoplasms
Ultrasound, high - intensity focused
Therapy